| DAVNUO ELI LILLY AND COMPANY
2168180 23 Feb 2022 | on 10 Sep 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases | | | DAVNUO ELI LILLY AND COMPANY
2072064 17 Dec 2020 | on 16 Oct 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Coronavirus disease. | |